Case number 1:23-cv-01193
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 4, 2024 | 21 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,943,537. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 04/04/2024) (0) |
| Apr 3, 2024 | 20 | SO ORDERED, re (168 in 1:19-cv-02309-JLH, 19 in 1:23-cv-01193-JLH, 19 in 1:22-cv-01611-JLH, 117 in 1:21-cv-00838-JLH) Stipulation and Order of Dismissal between Plaintiffs and Defendants Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd., and AurobindoPharma USA, Inc. Signed by Judge Jennifer L. Hall on 4/3/2024. Associated Cases: 1:19-cv-02309-JLH, 1:21-cv-00838-JLH, 1:22-cv-01611-JLH, 1:23-cv-01193-JLH(ceg) (Entered: 04/03/2024) (3) |
| Apr 3, 2024 | N/A | CASE CLOSED per D.I. 20 . (ceg) (Entered: 04/03/2024) (0) |
| Apr 2, 2024 | 19 | STIPULATION of Dismissal with Prejudice by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd.. (Whitesell, Angela) (Entered: 04/02/2024) (3) |
| Jan 31, 2024 | 18 | SO ORDERED, re 17 Joint Stipulation to Stay Deadlines. (*See Order for details). Signed by Judge Jennifer L. Hall on 1/31/2024. (ceg) (Entered: 01/31/2024) (4) |
| Jan 31, 2024 | N/A | Case Stayed per D.I. 18 . (ceg) (Entered: 01/31/2024) (0) |
| Jan 29, 2024 | 17 | Joint STIPULATION to Stay Deadlines - filed by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. (Whitesell, Angela) Modified on 1/29/2024 (ceg). (Entered: 01/29/2024) (4) |
| Jan 5, 2024 | N/A | Case Assigned to Judge Jennifer L Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:19-cv-02309-JLH, 1:19-cv-02321-JLH, 1:19-cv-02342-JLH, 1:19-cv-02368-JLH, 1:21-cv-00838-JLH, 1:22-cv-01480-JLH, 1:22-cv-01611-JLH, 1:23-cv-00008-JLH, 1:23-cv-01193-JLH(rjb) (Entered: 01/05/2024) (0) |
| Nov 20, 2023 | N/A | SO ORDERED, 14 Stipulation and Order to Extend Time for the parties to confer regarding coordination of the cases and submit a proposed scheduling order to the Court to January 30, 2024. Ordered by Judge Jennifer L. Hall on 11/20/2023. (ceg) (Entered: 11/20/2023) (0) |
| Nov 17, 2023 | 16 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd., Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. Case reassigned to Magistrate Judge Jennifer L. Hall. Signed by Judge Colm F. Connolly on 11/17/2023. (nmf) (Entered: 11/17/2023) (6) |
| Nov 16, 2023 | 14 | STIPULATION TO EXTEND TIME for the parties to confer regarding coordination of the cases and submit a proposed scheduling order to the Court to January 30, 2024 - filed by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd.. (Whitesell, Angela) (Entered: 11/16/2023) (4) |
| Nov 16, 2023 | 15 | Joint NOTICE of Consent to Proceed Before a United States Magistrate Judge by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. (Whitesell, Angela) (Entered: 11/16/2023) (6) |
| Nov 15, 2023 | 13 | ANSWER to 10 Answer to Complaint, Counterclaim by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd..(Whitesell, Angela) (Entered: 11/15/2023) (11) |
| Nov 3, 2023 | N/A | Pro Hac Vice Attorneys Tracy Block, Marcelo Barros, Michael A. Sitzman, Shuzo Maruyama, Megan E. Bowers, and Raymond A. Miller for Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 11/03/2023) (0) |
| Nov 2, 2023 | 12 | ORDER, having been assigned this case which is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before December 4, 2023, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/4/2023.) Signed by Judge Colm F. Connolly on 11/2/2023. (nmf) (Entered: 11/02/2023) (1) |
| Oct 30, 2023 | 10 | ANSWER to 1 Complaint, , COUNTERCLAIM against Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd. by Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd., Aurobindo Pharma Ltd..(Dorsney, Kenneth) (Entered: 10/30/2023) (30) |
| Oct 30, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited, Corporate Parent Mviyes Pharma Ventures Private Limited for Eugia Pharma Specialities Ltd.; Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma U.S.A., Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd.. (Dorsney, Kenneth) (Entered: 10/30/2023) (2) |
| Oct 30, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Michael Sitzman, Raymond Miller, Shuzo Maruyama, Megan E. Bowers, Tracy Block, and Marcelo Barros, filed by Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc. Ordered by Judge Colm F. Connolly on 10/30/2023. (kmd) (Entered: 10/30/2023) (0) |
| Oct 27, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Michael Sitzman, Raymond Miller, Shuzo Maruyama, Megan E. Bowers, Tracy Block, and Marcelo Barros - filed by Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd.. (Whitesell, Angela) (Entered: 10/27/2023) (10) |
| Oct 25, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 10/25/2023) (0) |
| Oct 25, 2023 | 8 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 10/25/2023) (2) |
| Oct 24, 2023 | 6 | Summons Issued as to Aurobindo Pharma U.S.A., Inc. on 10/24/2023. (mkr) (Entered: 10/24/2023) (2) |
| Oct 24, 2023 | 7 | SUMMONS Returned Executed by Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc..Aurobindo Pharma U.S.A., Inc. served on 10/24/2023, answer due 11/14/2023. (Whitesell, Angela) (Entered: 10/24/2023) (2) |
| Oct 20, 2023 | 1 | Complaint* (1) |
| Oct 20, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 10/20/2023) (3) |
| Oct 20, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/11/2023. Date of Expiration of Patent: 9/5/2034.Thirty Month Stay Deadline: 3/11/2026. (mkr) (Entered: 10/20/2023) (1) |
| Oct 20, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) U.S. 9,943,537. (mkr) (Entered: 10/20/2023) (1) |
| Oct 20, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Taiho Pharmaceutical Co., Ltd. for Taiho Oncology, Inc.; Corporate Parent Otsuka Holdings Co., Ltd. for Taiho Pharmaceutical Co., Ltd. filed by Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. (mkr) (Entered: 10/20/2023) (2) |
| Oct 20, 2023 | N/A | No Summons Issued. (mkr) (Entered: 10/20/2023) (0) |
